None of the current shareholders had exercised its preemptive rights to underwrite the new shares during the approved period. According the approval made by The General Meeting now The Board of Directors is appointed to invite new shareholder(s) for underwriting. The Board of Directors will try to attract an investor which can contribute to the further development of the company's business. The new shares will not bear any special rights and are not expected to be introduced to the public market.
The target underwriting price will be set higher than former underwriting price of 1'533'954 Series C shares (CZK 20,5), which will guarantee that the corresponding share on value of equity for Series C shareholders will not decrease.
The Board of Directors has not made any decision and has not performed any action in this matter yet.
Summary of the approved capital increase:
Current capital 13.021.554,- CZK 496.437,43 EUR
approved underwriting 500.000,- CZK 19.062,- EUR
underwriting above this amount is allowed up to the maximum underwriting
maximum underwriting 5.000.000,- CZK 190.620,- EUR
Osoby reprezentujące spółkę:
- Jaromir Proks - CFO
Źródło:Komunikaty spółek (EBI)
